Digital Signatures Presented at Electronic Document Management Conference

ARX, provider of the CoSign® digital signature solution, to present the use of digital signatures in clinical trial management applications at the DIA EDM Global Content Management in an Electronic World conference.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
“The use of digital signatures powerfully streamlines processes, especially in environments where there is a heavy flow of controlled documentation exchanged between various parties collaborating on clinical studies."

San Francisco, CA (PRWEB) February 12, 2010

ARX, the leading provider of digital signature solutions, will be presenting at the upcoming DIA’s 23rd Annual Electronic Document Management Conference, “Global Content Management in an Electronic World”. The event offers participants the opportunity to discuss the challenges associated with managing information in a global environment while maintaining national and regional regulatory compliance, and the ways in which the life sciences industry has progressed towards realizing the goal of an “e-only environment”.

Rodd Schlerf, Life Sciences Market Manager at ARX, will be presenting at the conference on the benefits of implementing a digital signature solution in clinical environments where there is still prevalent use of paper documents that require compliant approvals. He will discuss the use of digital signatures in clinical applications from various perspectives, including their use by Clinical Research Organizations (CROs) and Sponsors, and the ways in which digital signatures significantly cut costs and expedite business processes including clinical site / study initiation and reporting.

“The use of digital signatures powerfully streamlines processes, especially in environments where there is a heavy flow of controlled documentation exchanged between various parties collaborating on clinical studies,” said Mr. Schlerf. “As electronic solutions are adopted across organizations conducting regulatory operations, the ability to seamlessly authorize and transmit documents becomes an essential need.”

Mr. Schlerf’s presentation will take place on February 17th at 3:30PM at the Gaylord National Convention Center in National Harbor, Maryland. The session will also include speakers from SAFE BioPharma and GlaxoSmithKline.

About CoSign Digital Signatures in Life Sciences
ARX’s CoSign digital signature solution fully automates workflows, allowing organizations to go paperless, expedite business processes, and eliminate the expenses and time allocations that paper-based signatures require. Via its standards-based underpinnings, the CoSign® digital signature solution ensures signer intent, document integrity and compliance, while significantly streamlining business processes. CoSign creates a truly collaborative environment for the multiple parties involved in the life sciences ecosystem, expediting approvals spanning geographic locations or even multiple organizations. Watch a demo to learn more about how life sciences organizations can benefit from CoSign.

About The Digital Signature Company - ARX
ARX (Algorithmic Research) is a global provider of cost-efficient digital signature solutions for industries such as life sciences, healthcare, government, engineering, and energy. ARX engineers and scientists have more than 20 years of experience in security and standard digital signature application. ARX helps businesses secure, streamline, and scale their processes and transactions with the proper controls required by legislation, regulation, and industry best practice. Visit us at http://www.arx.com.

CoSign is a registered trademark and CoSign PSF is a trademark of Algorithmic Research, Ltd. All other trade names and trademarks are the property of their respective holders.

###


Contact

Attachments